Cargando…

Synthetic receptor platform to identify loss-of-function single nucleotide variants and designed mutants in the death receptor Fas/CD95

Synthetic biology has emerged as a useful technology for studying cytokine signal transduction. Recently, we described fully synthetic cytokine receptors to phenocopy trimeric receptors such as the death receptor Fas/CD95. Using a nanobody as an extracellular-binding domain for mCherry fused to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Minafra, Anna Rita, Rafii, Puyan, Mossner, Sofie, Bazgir, Farhad, Floss, Doreen M., Moll, Jens M., Scheller, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413154/
https://www.ncbi.nlm.nih.gov/pubmed/37392849
http://dx.doi.org/10.1016/j.jbc.2023.104989
_version_ 1785087074754363392
author Minafra, Anna Rita
Rafii, Puyan
Mossner, Sofie
Bazgir, Farhad
Floss, Doreen M.
Moll, Jens M.
Scheller, Jürgen
author_facet Minafra, Anna Rita
Rafii, Puyan
Mossner, Sofie
Bazgir, Farhad
Floss, Doreen M.
Moll, Jens M.
Scheller, Jürgen
author_sort Minafra, Anna Rita
collection PubMed
description Synthetic biology has emerged as a useful technology for studying cytokine signal transduction. Recently, we described fully synthetic cytokine receptors to phenocopy trimeric receptors such as the death receptor Fas/CD95. Using a nanobody as an extracellular-binding domain for mCherry fused to the natural receptor’s transmembrane and intracellular domain, trimeric mCherry ligands were able to induce cell death. Among the 17,889 single nucleotide variants in the SNP database for Fas, 337 represent missense mutations that functionally remained largely uncharacterized. Here, we developed a workflow for the Fas synthetic cytokine receptor system to functionally characterize missense SNPs within the transmembrane and intracellular domain of Fas. To validate our system, we selected five functionally assigned loss-of-function (LOF) polymorphisms and included 15 additional unassigned SNPs. Moreover, based on structural data, 15 gain-of-function or LOF candidate mutations were additionally selected. All 35 nucleotide variants were functionally investigated through cellular proliferation, apoptosis and caspases 3 and 7 cleavage assays. Collectively, our results showed that 30 variants resulted in partial or complete LOF, while five lead to a gain-of-function. In conclusion, we demonstrated that synthetic cytokine receptors are a suitable tool for functional SNPs/mutations characterization in a structured workflow.
format Online
Article
Text
id pubmed-10413154
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Society for Biochemistry and Molecular Biology
record_format MEDLINE/PubMed
spelling pubmed-104131542023-08-11 Synthetic receptor platform to identify loss-of-function single nucleotide variants and designed mutants in the death receptor Fas/CD95 Minafra, Anna Rita Rafii, Puyan Mossner, Sofie Bazgir, Farhad Floss, Doreen M. Moll, Jens M. Scheller, Jürgen J Biol Chem Research Article Synthetic biology has emerged as a useful technology for studying cytokine signal transduction. Recently, we described fully synthetic cytokine receptors to phenocopy trimeric receptors such as the death receptor Fas/CD95. Using a nanobody as an extracellular-binding domain for mCherry fused to the natural receptor’s transmembrane and intracellular domain, trimeric mCherry ligands were able to induce cell death. Among the 17,889 single nucleotide variants in the SNP database for Fas, 337 represent missense mutations that functionally remained largely uncharacterized. Here, we developed a workflow for the Fas synthetic cytokine receptor system to functionally characterize missense SNPs within the transmembrane and intracellular domain of Fas. To validate our system, we selected five functionally assigned loss-of-function (LOF) polymorphisms and included 15 additional unassigned SNPs. Moreover, based on structural data, 15 gain-of-function or LOF candidate mutations were additionally selected. All 35 nucleotide variants were functionally investigated through cellular proliferation, apoptosis and caspases 3 and 7 cleavage assays. Collectively, our results showed that 30 variants resulted in partial or complete LOF, while five lead to a gain-of-function. In conclusion, we demonstrated that synthetic cytokine receptors are a suitable tool for functional SNPs/mutations characterization in a structured workflow. American Society for Biochemistry and Molecular Biology 2023-06-29 /pmc/articles/PMC10413154/ /pubmed/37392849 http://dx.doi.org/10.1016/j.jbc.2023.104989 Text en © 2023 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Article
Minafra, Anna Rita
Rafii, Puyan
Mossner, Sofie
Bazgir, Farhad
Floss, Doreen M.
Moll, Jens M.
Scheller, Jürgen
Synthetic receptor platform to identify loss-of-function single nucleotide variants and designed mutants in the death receptor Fas/CD95
title Synthetic receptor platform to identify loss-of-function single nucleotide variants and designed mutants in the death receptor Fas/CD95
title_full Synthetic receptor platform to identify loss-of-function single nucleotide variants and designed mutants in the death receptor Fas/CD95
title_fullStr Synthetic receptor platform to identify loss-of-function single nucleotide variants and designed mutants in the death receptor Fas/CD95
title_full_unstemmed Synthetic receptor platform to identify loss-of-function single nucleotide variants and designed mutants in the death receptor Fas/CD95
title_short Synthetic receptor platform to identify loss-of-function single nucleotide variants and designed mutants in the death receptor Fas/CD95
title_sort synthetic receptor platform to identify loss-of-function single nucleotide variants and designed mutants in the death receptor fas/cd95
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413154/
https://www.ncbi.nlm.nih.gov/pubmed/37392849
http://dx.doi.org/10.1016/j.jbc.2023.104989
work_keys_str_mv AT minafraannarita syntheticreceptorplatformtoidentifylossoffunctionsinglenucleotidevariantsanddesignedmutantsinthedeathreceptorfascd95
AT rafiipuyan syntheticreceptorplatformtoidentifylossoffunctionsinglenucleotidevariantsanddesignedmutantsinthedeathreceptorfascd95
AT mossnersofie syntheticreceptorplatformtoidentifylossoffunctionsinglenucleotidevariantsanddesignedmutantsinthedeathreceptorfascd95
AT bazgirfarhad syntheticreceptorplatformtoidentifylossoffunctionsinglenucleotidevariantsanddesignedmutantsinthedeathreceptorfascd95
AT flossdoreenm syntheticreceptorplatformtoidentifylossoffunctionsinglenucleotidevariantsanddesignedmutantsinthedeathreceptorfascd95
AT molljensm syntheticreceptorplatformtoidentifylossoffunctionsinglenucleotidevariantsanddesignedmutantsinthedeathreceptorfascd95
AT schellerjurgen syntheticreceptorplatformtoidentifylossoffunctionsinglenucleotidevariantsanddesignedmutantsinthedeathreceptorfascd95